The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study
- 1 April 2005
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (1) , 104-109
- https://doi.org/10.1016/j.ygyno.2004.12.026
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experienceCancer, 2010
- Ovarian cancer: Survival and treatment differences by ageCancer, 2010
- Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?Obstetrics & Gynecology, 2003
- Use of Adjuvant Chemotherapy and Radiation Therapy for Colorectal Cancer in a Population-Based CohortJournal of Clinical Oncology, 2003
- Age Contrasts in Clinical Characteristics and Pattern of Care in Patients with Epithelial Ovarian CancerGynecologic Oncology, 2002
- Epithelial ovarian carcinoma in the reproductive age groupCancer, 1999
- FIGO staging of gynecologic cancerInternational Journal of Gynecology & Obstetrics, 1999
- Comorbidity and functional status are independent in older cancer patients.Journal of Clinical Oncology, 1998
- The national institute on aging and the national cancer institute seer collaborative study on comorbidity and early diagnosis of cancer in the elderlyCancer, 1994
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987